Dyskeratosis congenita: its link to telomerase and aplastic anaemia

被引:71
|
作者
Dokal, I [1 ]
Vulliamy, T [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, Div Investigat Sci,Fac Med, London W12 0NN, England
关键词
aplastic anaemia; dyskerin; dyskeratosis congenita; Hoyeraal-Hreidarsson syndrome; telomerase;
D O I
10.1016/S0268-960X(03)00020-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome exhibiting considerable clinical and genetic heterogeneity. X-linked recessive, autosomal dominant and autosomal recessive forms are recognised. The gene mutated in X-linked DC (DKCI) encodes a highly conserved nucleolar protein called dyskerin. Dyskerin associates with the H/ACA class of small nucleolar RNAs which are important in guiding the conversion of uracil to pseudouracil in ribosomal RNA. Dyskerin also associates with the RNA component of telomerase (hTR) which is important in the maintenance of telomeres. Mutations in hTR were recently demonstrated in patients with autosomal dominant DC and in a subset of patients with aplastic anaemia (AA) but without other diagnostic features of DC. This discovery demonstrates that both DC and a subset of AA are due to a defect in telomerase. The link between DC and AA and in turn to defective telomerase suggests that treatments directed at correction of telomerase activity might benefit DC/AA patients who do not respond to conventional therapy. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 50 条
  • [1] Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA
    Fogarty, PF
    Yamaguchi, H
    Wiestner, A
    Baerlocher, GM
    Sloand, E
    Zeng, WHS
    Read, EJ
    Lansdorp, PM
    Young, NS
    LANCET, 2003, 362 (9396): : 1628 - 1630
  • [2] Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita
    Langston, AA
    Sanders, JE
    Deeg, HJ
    Crawford, SW
    Anasetti, C
    Sullivan, KM
    Flowers, MED
    Storb, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (03) : 758 - 765
  • [3] Dyskeratosis congenita and telomerase
    Bessler, M
    Wilson, DB
    Mason, PJ
    CURRENT OPINION IN PEDIATRICS, 2004, 16 (01) : 23 - 28
  • [4] Telomerase dysfunction and dyskeratosis congenita
    Amanda J. Walne
    Inderjeet Dokal
    Cytotechnology, 2004, 45 : 13 - 22
  • [5] Telomerase dysfunction and dyskeratosis congenita
    Walne, AJ
    Dokal, I
    CYTOTECHNOLOGY, 2004, 45 (1-2) : 13 - 22
  • [6] Dyskeratosis congenita: telomerase, telomeres and anticipation
    Marrone, A
    Walne, A
    Dokal, I
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (03) : 249 - 257
  • [7] Stem cells, telomerase and dyskeratosis congenita
    Mason, PJ
    BIOESSAYS, 2003, 25 (02) : 126 - 133
  • [8] Human telomerase mutations in dyskeratosis congenita
    不详
    CLINICAL BIOCHEMISTRY, 2005, 38 (09) : 840 - 840
  • [9] Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency
    Marrone, A
    Stevens, D
    Vulliamy, T
    Dokal, I
    Mason, PJ
    BLOOD, 2004, 104 (13) : 3936 - 3942
  • [10] FANCONIS ANAEMIA AND DYSKERATOSIS CONGENITA AS A SYNDROME
    BODALSKI, J
    DEFECINS.E
    PACANOWS.M
    JUDKIEWI.L
    DERMATOLOGICA, 1963, 127 (04): : 330 - &